December 21, 2022
UK and US Offices receive Charity status
UK and US Offices receive Charity status
Medicines Development for Global Health affiliate offices in the United States and United Kingdom have now both received charity designations. In the United States, Medicines Development for Global Health, Inc., headquartered in Montclair, New Jersey, received on 9 May 2022 the tax-exempt 501(c)(3) public charity status. In the United Kingdom, Medicines Development for Global Health Limited, headquartered in Cambridge, UK, was registered as a Charity in England and Wales on 7 October 2022 and entered onto the Register of Charities with the Registered Charity Number 1200620. This milestone means that all Medicines Development for Global Health offices now can receive tax deductible donations and gifts in Australia, United States and United Kingdom..
-End